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Wingless (Wnt) is a potent morphogen demonstrated
in multiple cell lineages to promote the expansion
andmaintenance of stem and progenitor cell popula-
tions. Wnt effects are highly context dependent, and
varying effects of Wnt signaling on hematopoietic
stem cells (HSCs) have been reported. We explored
the impact of Wnt signaling in vivo, specifically in
the context of the HSC niche by using an osteo-
blast-specific promoter driving expression of the
paninhibitor of canonical Wnt signaling, Dickkopf1
(Dkk1). Here we report that Wnt signaling was mark-
edly inhibited in HSCs and, unexpectedly given prior
reports, reduction in HSC Wnt signaling resulted in
reduced p21Cip1 expression, increased cell cycling,
and a progressive decline in regenerative function
after transplantation. This effect was microenviron-
ment determined, but irreversible if the cells were
transferred to a normal host. Wnt pathway activation
in the niche is required to limit HSC proliferation and
preserve the reconstituting function of endogenous
hematopoietic stem cells.
INTRODUCTION
The regulation of hematopoietic stem cell function is a complex
and balanced process that requires coordinated input from in-
herent HSC programs and moderating signals provided by the
surrounding microenvironment. Together, these signals permit
the maintenance of the stem cell pool for the life of the organism,
while also allowing for sufficient steady-state and injury-respon-
sive blood cell production. These somewhat dichotomous as-
pects of HSC function require mechanisms that both preserve
a quiescent population of stem cells and also promote their ac-
tivation, expansion, differentiation, and circulation under appro-
priate conditions (Akala and Clarke, 2006; Scadden, 2006). The
morphogen family of signaling molecules has been identified
as a prominent player in the function of numerous stem cell
types, including the hematopoietic lineage. The wingless (Wnt)274 Cell Stem Cell 2, 274–283, March 2008 ª2008 Elsevier Inc.pathway has been studied extensively in the context of hemato-
poiesis, and the combined impact of multiple family members
binding to a range of receptors leads to activation of canonical
and noncanonical signaling pathways (Nemeth and Bodine,
2007). Canonical signals are mediated by TCF/LEF transcription
factor activity (Daniels andWeis, 2005), and are considered to be
largely dependent on the accumulation of nuclear b- (and/or g-)
catenin (Nemeth and Bodine, 2007). Wnt signals have been im-
plicated in mammalian hematopoiesis by studies not intended
to assess normal physiology inwhichWnt activation had a strong
expansive effect on reconstituting HSCs and multipotent pro-
genitors (Baba et al., 2006; Murdoch et al., 2003; Reya et al.,
2003; Trowbridge et al., 2006b). With enforced, persistent Wnt
activation, however, engineered mice developed hematopoietic
failure with impaired differentiation of HSC (Kirstetter et al., 2006;
Scheller et al., 2006). In contrast, deletion of members of the
Wnt/b-catenin cascade under homeostatic conditions had little
to no effect on blood cell production by HSCs (Cobas et al.,
2004; Jeannet et al., 2008; Koch et al., 2008), raising the question
of what physiological role, if any, Wnt signaling has on this cell
type. Some of the variation observed may reflect differing influ-
ences exerted by canonical versus noncanonical Wnt signals,
particularly given a recent report indicating that Wnt5a can mod-
ulate canonical signals mediated byWnt3a (Nemeth et al., 2007).
Wnt signals are also regulated by a host of soluble inhibitors that
may interact directly with Wnt ligands, such as the frizzled-re-
lated proteins (sFRP), or by preventing Wnt binding to its recep-
tors (Kawano and Kypta, 2003). The Dickkopf (Dkk) family of Wnt
inhibitors falls into this latter category, by binding the Wnt core-
ceptor LRP5/6 in combination with a Kremen receptor, and lead-
ing to internalization of the complex (Mao et al., 2001, 2002). In
order to specifically examine the impact of Wnt activation in an
in vivo microenvironment that has been shown to regulate HSC
number and function, we utilized mice engineered to overex-
press the Wnt inhibitor, Dkk1, under control of the osteoblast-
specific 2.3 kb fraction of the collagen1a (Col1a) promoter.
This promoter has been previously shown to direct transgene ex-
pression to osteoblastic cells, resulting in changes in the number
and function of HSCs (Calvi et al., 2001, 2003).
We noted very little overt phenotype in the hematopoietic
compartment of the Dkk1 tg mice at steady state, and confirmed
that transgene expression did not extend to the primitive
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Endosteal Wnt Signaling Induces HSC Quiescencehematopoietic fraction itself. Clear alterations of bone morphol-
ogy were observed, however, including a 20% decrease in tra-
becular bone (J.G., M. Liu, D. Yang, M. Bouxsein, H. Saito,
R. Baron, R. Bringhurst, and H.M.K., unpublished data). Despite
the absence of a steady-state hematopoietic phenotype, TCF/
LEF activity was specifically reduced within the HSC-containing
fraction of Dkk1 transgenic (Dkk1 tg) mice, and stem cell function
was altered under specific conditions. For example, a highly sig-
nificant defect in the maintenance of reconstitution potential of
HSC was observed, either in settings of serial transplant, or fol-
lowing secondary transplantation of wild-type donor cells previ-
ously used to reconstitute Dkk1 tg hosts. In agreement with the
functional data, HSC populations had a marked reduction of
cells within the G0 fraction of the cell cycle, and displayed en-
hanced sensitivity to 5-fluorouracil treatment. Wnt signals there-
fore appear to participate in mediating HSC quiescence in vivo,
a result that was largely unpredicted from previous studies, al-
though recent analysis of Hmgb3 mutant mice also supports
this conclusion (Nemeth et al., 2006). Our results highlight the im-
portance of studying the impact of a signaling pathway over
long-term experiments, and in a physiologic context when seek-
ing to resolve the effects of manipulations on HSC function. In
that context, Wnt signaling plays an unanticipated role in main-
taining HSC quiescence, which may underlie its requirement in
preserving the self-renewing capability of HSCs.
RESULTS
Osteoblast Expression of Dkk1 Does Not Affect Blood
or Marrow Primitive Hematopoietic Cell Populations
at Steady State
The Wnt inhibitor, Dkk1, has been shown to play an important
role in bone formation during development (Niehrs, 2006) and
is normally expressed by osteoblasts (Grotewold et al., 1999;
MacDonald et al., 2004), hence it may have regulatory roles as
part of the endosteal HSC niche. To examine the impact of
Wnt inhibition on hematopoietic stem cells localized to the peri-
endosteal region, Dkk1 was overexpressed within osteoblastic
lineage cells under the control of the truncated 2.3 kb Col1a pro-
moter (J.G., M. Liu, D. Yang, M. Bouxsein, H. Saito, R. Baron,
R.Bringhurst, andH.M.K., unpublished data). ResultingCol1a2.3-
Dkk1 tgmicewere backcrossed for at least five generations to the
C57Bl/6 background and examined for bone and blood pheno-
typic alterations. No significant differences in peripheral white
or red blood cell counts were observed (see Figure S1A available
online). Bone marrow (BM) cellularity and spleen cellularity were
also unchanged when Dkk1 tg mice and their littermates were
compared, although a slight but not significant trend toward
reduced body weight and BM cellularity was apparent in trans-
genic mice (Figure S1B and data not shown). In contrast, signif-
icant alterations in bone morphology were observed, as is re-
ported elsewhere (J.G., M. Liu, D. Yang, M. Bouxsein, H. Saito,
R. Baron, R. Bringhurst, and H.M.K., unpublished data; and Li
et al. [2006]). Of note, trabecular bone volume was reduced by
20%, whereas cortical bone was unaffected in Dkk1 tg mice
(data not shown). Trabecular bone has been shown by us and
others to affect HSC number and function (Adams et al., 2007;
Calvi et al., 2003; Jung et al., 2007; Zhang et al., 2003). A panel
of antibodies using seven different fluorochromes was used formultiparametric analysis of primitive precursors within the BM
of Dkk1 tg mice and their littermates, including populations of
LT-HSC, ST-HSC, CMP, GMP, MEP, and CLP (Figures 1A and
1C). Subpopulations containing primitive HSCs were not signifi-
cantly altered at steady state (Figure 1B). However, additional
cell surface markers revealed a slight but significant increase in
the population containing phenotypically defined common lym-
phoid progenitors (Figure 1D). The calculated absolute cell num-
bers based on these frequencies indicated a similar pattern of
results (Figure S2). Despite the elevation of early lymphoid pro-
genitors in the BM of Dkk1 tg mice, no significant changes
were observed in the relative proportion of early B lineage pro-
genitor subsets in the BM (data not shown).
Dkk1 tg HSCs Exhibit Impaired Wnt Signaling
in a Non-Cell Autonomous Manner
To confirm that the transgenic expression of Dkk1 leads to the
inhibition of Wnt/b-catenin signaling in the Dkk1 tg mice, HSC-
containing populations were isolated from Dkk1 tg mice that
had been intercrossed with the Topgal reporter strain. In these
Topgal mice (DasGupta and Fuchs, 1999), multiple TCF/LEF
binding sites have been inserted to control the expression of
the reporter gene, b-galactosidase. Reporter activity using this
construct has been shown to correlate with canonical Wnt sig-
naling. Of note, TCF/LEF transcription has recently been shown
to proceed even with the combined loss of b-catenin and g-cat-
enin, suggesting that canonical Wnt signals can be transduced
by alternate intermediates (Jeannet et al., 2008). Reporter activ-
ity was examined within the LK+S+ (Lineage-cKit+Sca1+), HSC-
containing population, and the LK+S population that is devoid
of LT-HSC potential. When the Wnt reporter activity detected
in each of these populations was compared, a dramatic reduc-
tion (>100-fold reduction) in b-catenin activation was observed
in the HSC-containing LK+S+ population isolated from Dkk1 tg
mice (Figure 2A). A more modest reduction (<5-fold reduction)
was observed in the less actively signaling LK+S fraction. This
finding indicates that despite the unchanged frequency of phe-
notypically defined HSC-containing populations in unmanipu-
lated Dkk1 tg animals, there is evidence that these cells are mo-
lecularly altered by osteoblast expression of the Wnt inhibitor.
These data provide evidence for direct inhibition of Wnt signaling
in the HSCpopulation in addition to any effects that might beme-
diated by decreased trabecular bone mass. Wnt signaling is reg-
ulated, in part, via a negative feedback loop by TCF/LEF-depen-
dent transcription of endogenous Dkk1 (Niida et al., 2004).
Consistent with the decrease in Topgal reporter activity, expres-
sion of endogenous Dkk1 was also inhibited in the LK+S+ popu-
lation of Dkk1 tg mice (Figure 2B). Using primers specific for the
Dkk1 tg, and in comparison with its expression in WT and Dkk1
tg tibiae, sorted LK+S+ cells do not express the Dkk1 transgene
(Figure 2C). Together, these results confirm that Dkk1 tg mice
inhibit Wnt signaling specifically within the HSC compartment
in a non-cell autonomous manner.
Functional Impact of the Dkk1 Transgene
on BM Reconstitution
Analysis of stem/progenitor activity cannot rely exclusively on the
quantitation of precursors according to phenotypically defined
parameters.Using functionalmeasures,wedetectedaconsistentCell Stem Cell 2, 274–283, March 2008 ª2008 Elsevier Inc. 275
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Endosteal Wnt Signaling Induces HSC QuiescenceFigure 1. Seven-Color FACS Analysis of Primitive Populations in WT
and Dkk1 tg BM
BM from Dkk1 tg and littermates was assayed bymultiparameter FACS for rel-
ative proportion of primitive HSC populations. BMwas stained with antibodies
against Lineage markers, cKit, Sca-1, CD34, Flk2, CD16/32, and CD127 and
gated as shown in (A) and (C). At least ten mice per genotype were compared,
over at least three separate experiments. The proportion of BM corresponding
to the HSC-containing LK+S+ fraction (A, blue gate) is shown in (B) (left axis),
and is subsectioned according to CD34 and Flk2 expression to yield pheno-
typic assessments of LT-HSC and ST-HSC fractions (B, right axis). More dif-
ferentiated progenitors gated in the LK+S population (A, left, green gate)
were subsectioned based on CD16/32 and CD34 expression to compare
CMP, GMP, and MEP progenitors as shown in (C) (left panel). Frequencies
of each population, from the same samples quantified for HSC frequency in276 Cell Stem Cell 2, 274–283, March 2008 ª2008 Elsevier Inc.defect in multilineage and myeloid colony formation on a per-cell
basis inBM isolated fromDkk1 tgmice (Figure3A). This resultwas
despite the absence of significant alteration of myeloid andmore
primitive progenitors by immunophenotype, possibly reflecting
the elevated lymphoid fraction, whose progeny are not read out
under these culture conditions. In vitro methods such as the
CFU assay offer an entry-level analysis of hematopoietic activity;
however, functional reconstitution in vivo more accurately exam-
ines true HSC function (Purton and Scadden, 2007). Therefore, in
order to better assess the functional capacity of HSCs isolated
from the Dkk1 tg environment, BM was transplanted from WT
or Dkk1 tg littermates with an equivalent dose of competing
marrow from congenic donor mice into lethally irradiated recipi-
ents. Donor marrow was isolated from a single WT or transgenic
mouse to assess any individual-to-individual variation. Following
6months of engraftment, no significant changes in reconstitution
were observed across the groups of recipients receiving BM
isolated from individual WT or Dkk1 tg environments, although
a range of reconstitution capacity was apparent in both groups
(Figure S3A). Using a limiting dilution assay to determine the
frequency of repopulating cells present in BM isolated from indi-
vidual Dkk1-expressing animals revealed a 2-fold elevation in the
number of functional reconstituting HSCs (Figure 3B). These
transplant results indicate that cells isolated from the Dkk1-ex-
pressing niche are capable of reconstituting irradiated recipients
and appear to be present at a higher frequency when Wnt has
been inhibited in this location. An important additional parameter
to testwhen investigatingHSC function is their longevity, or ability
to respond to repeated rounds of expansion stress. To assay the
longevity of HSCs isolated from Dkk1 tg mice, noncompetitive
serial transplantswereperformed.Asexpected from theprevious
transplant experiments, Dkk1 tg BM was able to completely re-
constitute WT irradiated recipients (data not shown). However,
following two subsequent transplantations, each after a period
of 14weeks of reconstitution, Dkk1 tg-derivedHSCswere unable
to rescue irradiated hosts under the same conditions supported
by littermate BM donors (Figure 3C). Highly significant differ-
ences in the survival curves of the tertiary transplanted recipients
are depicted, andwere similar in an independent serial transplant
experiment using multiple donors. Consistent with the decrease
in survival after multiple transplants, a reduction in the frequency
of phenotypic LT-HSCs was also detected in the BM of Dkk1 tg
secondary hosts used as donors for tertiary transplants (Fig-
ure 3D). Together, these results demonstrate that HSCs are
functional following isolation from a Dkk1-expressing endosteal
environment, but their long-term function is not maintained over
sequential transplantations. A forced, repeated expansion re-
quirement imposed on cells that have once been exposed to
the Wnt-inhibited environment results in their early expiration.
Effect of Temporary Exposure to Endosteal Dkk1
on HSC Function
Transplantation of BM cells from unmanipulated Dkk1 tg donors
allows the assessment of the functional capacity of HSCs
(B), are shown in (D) (left axis). The CLP fraction, gated on LKloSlo in (A) (red
gate), and gated further on CD127+ cells in (C) (right panel) are quantified in
(D) (right axis). Significance was determined by a Student’s 2-tailed t test. Error
bars indicate the SE of the mean.
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Endosteal Wnt Signaling Induces HSC Quiescencefollowing chronic exposure to a Wnt-inhibited environment, as
the assayed cells have been exposed to the transgenic osteo-
blastic cells throughout development. To investigate the impact
of temporary exposure to osteoblast-produced Dkk1 on HSC
function in a situation of stress, WT or Dkk1 tg mice were lethally
irradiated and then transplanted with WT BM from CD45 con-
genic donors. Consistent with the results obtained in the trans-
plant of chronically Wnt-inhibited HSCs, Dkk1 tg mice were fully
reconstituted by WT donor cells, as measured by peripheral
white blood cell counts and the percent of multilineage, donor-
Figure 2. Assessment of Canonical Wnt Signal Activity in HSC-
Containing Populations of Dkk1 tg Mice
Dkk1 tg mice were crossbred with Topgal transgenic mice. Three pairs of top-
gal+ littermates, with and without the Dkk1 tg, were used to isolate the HSC-
containing LK+S+ primitive fraction, and more differentiated LK+S cells.
FACS-sorted populations were used to isolate mRNA and assessed for ex-
pression of the Topgal reporter. Data are expressed as the relative Topgal
mRNA expression, compared to the levels present in LK+S+WT cells (A). Three
pairs of Dkk1 tg andWT littermates were also used to isolate the LK+S+ fraction
of BM, from which mRNA was isolated (non-Topgal transgenics) (B). mRNA
was also isolated from the tibiae (bone + marrow) of WT and Dkk1 tg mice.
Quantitative PCR was performed using primers specific for the Dkk1 trans-
gene. Data are expressed as the relative amount of Dkk1 mRNA compared
to that found in WT tibiae (C), and error bars indicate SE of the mean.derived cells detected within the circulation of reconstituted an-
imals (Figure 4A and data not shown). These findings suggest
that HSC function is not prevented in a setting that inhibits Wnt
via Dkk1 overexpression within the HSC niche. In stark contrast
with the competent function of donor cells in primary Dkk1 tg re-
cipients, BM isolated from individual reconstituted hosts was un-
able to efficiently competitively repopulate lethally irradiated
secondary WT recipients (Figure 4B). Consistent with the loss
of HSC function following only 14 weeks of exposure to the
Dkk1 tg host environment, reconstituted BM cells that had
been resident in Dkk1 tg hosts did not yield as many primitive
myeloid colonies in a CFC assay (Figure S3B). Therefore, the ad-
verse effect of Dkk1 exposure was not limited to cells that devel-
oped within the transgenic environment, but could also be in-
duced by transplantation of adult cells into an adult BM niche
that overexpressed the Wnt inhibitor.
Wnt-Inhibited HSC-Containing Populations
Are Less Quiescent
The long-term function of HSCs that permits them to support he-
matopoiesis even after several rounds of stress-induced expan-
sion, as mimicked by a serial transplant, is thought to depend on
maintaining a fraction of the population in a highly quiescent
state (Cheng et al., 2000; Hock et al., 2004; Yilmaz et al.,
2006). Multiparameter FACS analysis revealed that the HSC-
containing, LK+S+ population isolated from Dkk1 tg mice is spe-
cifically depleted of cells in the quiescent, G0 stage of the cell cy-
cle (Figure 5A). Indeed, greater fractionation of this population by
gating on LK+S+CD34low cells also revealed that Dkk1 tg mice
did not retain quiescent cells (Figure 5B). A similar trend was ob-
served when WT cells were examined following transplantation
and temporary exposure to the Wnt-inhibited environment
(data not shown). Cell-cycle analysis at a single time point may
not fully reflect the tendency of a population to initiate divisions
over time (Janzen et al., 2006). To examine the frequency of entry
into cell cycle based on the initiation of DNA synthesis, WT and
Dkk1 tg mice were exposed to BrdU for a period of 16–18 hr, fol-
lowed by analysis of BrdU incorporation within primitive BMpop-
ulations. When the LK+S+ population was fractionated into LT-
and ST-HSC populations, the proportion of BrdU-containing
cells was elevated in tg cells, significantly in the CD34+Flk2
population (Figure S4). These results suggest that Wnt-inhibited
HSCs are unable to maintain a population of quiescent cells, and
may provide an explanation for the reduced longevity of HSC
function observed in serial transplants. An additional method
that can assay for the presence of a population of quiescent
BM progenitors is to track the recovery of peripheral blood fol-
lowing treatment with the S phase-specific nucleoside analog,
5-fluorouracil (5-FU) (Randall and Weissman, 1997; Van Zant,
1984). Depletion of cycling cells following 5-FU treatment is fol-
lowed by a spike in newly generated whole blood cells (wbc)
emerging from a more quiescent, and therefore spared, stem/
progenitor pool. The time to recovery correlates with the relative
preservation of function of the stem/progenitor pool (Yeager
et al., 1983). In animals reconstituted with Dkk1 tg BM, there
was a significant lag in the ability of BM to replace the depleted
neutrophil pool (Figure 5C). The impact on total wbc was also
significant, if dampened (data not shown), due to the presence
of long-lived circulating lymphocytes. These findings suggestCell Stem Cell 2, 274–283, March 2008 ª2008 Elsevier Inc. 277
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Isolated from Dkk1 tg Mice
(A)BM fromeight pairs ofWTandDkk1 tgmicewas
plated inmethylcellulosewith growth factors (SCF,
IL-3, IL-6, Epo) and scored for CFU-C (combined
scoring for BFU-E, CFU-GM, andCFU-GEMMcol-
onies) after 12 days. All live colonies of more than
30 cells were counted for eachof threewells plated
per sample. Data are shown as mean colonies per
well for each of eight mice studied over three indi-
vidual experiments. Significance was determined
using a two-tailed Student’s t test.
(B) Limiting dilution experiments were performed
using three doses of test marrow (CD45.1) trans-
planted with 5 3 105 competing cells (CD45.2)
into groups of at least nine recipients (CD45.2)
per dose. Test marrow was isolated from two WT
and two Dkk1 tg mice, and the Dkk1 tg donors
shown here were transplanted into separate
groups of irradiated recipients. Data points are
plotted as the percent of recipients per group that
did not exhibit at least 1%multilineage PB engraft-
ment at 6 months (percent unreconstituted).
LT-HSC frequency and significance were deter-
mined using Poisson statistics: WT, 1 in 63,000
versus tg, 1 in 31,500 or 1 in 37,000; p < 0.02.
Similar results were obtained in an independent
assessment of two Dkk1 tg donors.
(C)Noncompetitive serial transplantswere initiated
by transplanting 1 3 106 whole BM pooled from
three WT or Dkk1 tg donors (CD45.1) into each of
ten irradiated recipients (CD45.2). Secondary and
tertiary transplants were performed after 14 weeks of engraftment by pooling BM from three to four reconstituted recipients to transplant 1 3 106 whole BM
into new groups of ten irradiated CD45.2 recipients. The Kaplan-Meier survival graph depicts the survival of tertiary recipients, mice receiving BM from Dkk1 tg
mice (solid line) or WT controls (dashed line). Similar results were obtained in an independent assessment of two WT and 2 Dkk1 tg mice.
(D) Prior to transplant into tertiary recipients, BM from five secondary recipients of both genotypes was assayed by FACS for the frequency of LT-HSCs
(LK+S+CD34lowFlk2). Error bars indicated SD of the mean, and significance was determined by a two-tailed t test.that the stem/progenitor population in Dkk1 tg-exposed BM ex-
hibits increased sensitivity to the toxic effects of 5-FU: a phenom-
enon expected with increased cell cycling. Indeed, only 40 hr af-
ter exposure to 5-FU, Dkk1 tg BM contains fewer phenotypically
primitive cells (Figure S4B), as measured by lineage and SLAM
family markers CD150 and CD48 (Kiel et al., 2005). No differ-
ences in the frequency of cells measured by cKit expression
were observed, likely due to modulation of this protein during
5-FU exposure (Randall and Weissman, 1997).
Consistent with the observed effect of Dkk-1 on stem cell cy-
cling, we detected a decrease in expression of the cyclin-depen-
dent kinase inhibitor, p21Cip1 within the Dkk1 tg LK+S+ popula-
tion (Figure 6). This cell-cycle regulator has been previously
noted by us to regulate stem cell cycling and, in its absence, an
acceleration in stem cell exhaustion (Cheng et al., 2000; Miyake
et al., 2006). Though not all studies agree, this effect of
p21Cip1 has also been documented in other stem cell systems
(Kippin et al., 2005; vanOs et al., 2007). A pathway demonstrated
under some circumstances to be affected by Wnt is Notch (Dun-
can et al., 2005), and we also observed a decline in expression of
theNotch pathway target, Hes-1 (Figure 6). Changes inHes-1 ex-
pression have been shown by others to directly affect HSC self-
renewal (Kunisato et al., 2003), perhaps by regulating p21 (Yu
et al., 2006). A similar reduction in Hes-1 expression was also ob-
served in the LK+S+ fraction of control BM used to reconstitute278 Cell Stem Cell 2, 274–283, March 2008 ª2008 Elsevier Inc.Dkk1 tg hosts (Figure S3B). In contrast, other transcription fac-
tors were unaffected by the presence of the osteoblastic-derived
Wnt inhibition (Figure 3C). These included Gfi-1, Bmi-1, and
HoxB4, each of which has been shown previously to play a role
in HSC self-renewal programs (Hock et al., 2004; Iwama et al.,
2004; Kyba et al., 2002; Park et al., 2003; Zeng et al., 2004).
DISCUSSION
Understanding the role of specific signals in the varied regulatory
functions of HSC activities is crucial for designing and develop-
ing therapeutic interventions involving these cells. The impact of
the Wnt family on the expansion and regulation of hematopoietic
cells has been examined in a variety of studies. However, the
physiologic effects of this pathway remain somewhat ill defined,
with often contradicting results. Some have demonstrated that
Wnt cascade activation promotes the proliferation of HSCs
and their progeny whilemaintaining at least short-term functional
activity (Baba et al., 2006;Murdoch et al., 2003; Reya et al., 2003;
Trowbridge et al., 2006b). Others, employing persistent genetic
activation of the pathway, have also demonstrated an increase
in proliferation of cells with an HSC immunophenotype, but
with marked impairment of HSC differentiation resulting in ani-
mal death (Kirstetter et al., 2006; Scheller et al., 2006). However,
induced deletion of b-catenin, the primary downstreammediator
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Function Following Residence in a Dkk1
tg Environment
Control, 13 106WTwhole BM cells (CD45.2) were
transplanted into each of five WT or Dkk1 tg irradi-
ated recipients (CD45.1). Peripheral blood was as-
sayed by FACS for engraftment by CD45.2 stain-
ing of wbc after 14 weeks (A). Contribution to
both B220+ and Mac1+ populations was con-
firmed. BM was harvested from two engrafted re-
cipients for each genotype, and groups of five irra-
diated WT CD45.1 secondary hosts received 9 3
105 CD45.2 cells from individual primary recipi-
ents, mixed with 33 105 fresh CD45.1 WT BM. PB engraftment of secondary recipients was assayed after 6 months (B). Data shown compare the reconstitution
from ten recipients ofWT-resident BM versus groups of fiveWT recipients transplantedwith BM from two individual Dkk1 tg hosts. Error bars are SD of themeans
in each case, with significance determined by two-tailed t tests. Similar results were obtained in a second experiment of two independently transplanted and
retransplanted Dkk1 tg hosts.of the Wnt cascade, resulted in no apparent impact on HSC ac-
tivity, even in a reconstitution assay that required expansion of
b-catenin null transplanted HSCs (Cobas et al., 2004). Further-
more, recent combined deletions of both b-catenin and its ho-
molog, g-catenin, also maintain HSC function under steady-
state and primary reconstitution conditions (Jeannet et al.,
2008; Koch et al., 2008). All of these studies have assayed Wnt
activity in either broad over- or under-stimulation settings, and
the manipulations have been performed on the HSCs them-
selves, or broadly applied to recipient animals. The context in
which morphogens are present is highly relevant to their effect
and not previously studied for Wnt effects on hematopoiesis
(Trowbridge et al., 2006a). Indeed, Wnt ligands can modulate
signaling initiated by other Wnt family members, underscoring
the concept that context and different signaling intermediates
may have a strong impact on functional outcome (Nemeth
et al., 2007).
In the present study, we have established a system that per-
mits the analysis of localizedWnt inhibition, offering the opportu-
nity to assay the impact of chronic or temporary exposure to this
inhibited environment. In particular, we have directed expression
of the Wnt inhibitor, Dkk1, to a cell population that has been pre-
viously demonstrated to exert a regulatory function over HSC ac-
tivity, and which normally express Dkk-1, albeit at lower levels
(Grotewold et al.,1999; MacDonald et al., 2004). It should be
noted that while an increasing number of reports suggest that
phenotypically identified HSCs inhabit additional physical loca-
tions within the BM environment (Kiel et al., 2005; Sipkins et al.,
2005), the promoter used in our study has proven to functionally
impact the number and activity of HSCs when used to direct
modifying signal expression to a population of osteoblastic cells.
Given that expression of Dkk1 also results in alterations to bone
morphology itself, there is likely to be a dual effect of Dkk1: one
altering the niche architecture and the other affectingWnt signal-
ing in stem/progenitor cells. Our studies demonstrated an effect
of Dkk1 overexpression by non-HSCs onWnt signaling in hema-
topoietic stem/progenitors, suggesting that this is at least a con-
tributing factor to the phenotype observed. This observation that
TCF/LEF reporter activity is reduced, as is expression of endog-
enous Dkk1, itself aWnt signaling target (Niida et al., 2004) in BM
cells of the transgenic mice, indicates altered canonical Wnt sig-
naling. It does not rule out that Dkk1may exert additional Wnt-in-
dependent functions. The results presented here also indicatethat the reduced longevity of HSCs does not require constant ex-
posure to exogenous Dkk1, given that we were unable to detect
Dkk1 tg expression within populations of primitive hematopoietic
cells, and therefore the functional impact on transplanted cells is
observed in a Dkk tg-free environment. It is important to note that
transplantation of whole BM populations is generally not effec-
tive at engrafting nonhematopoietic cells (Koc et al., 1999).
Wnt Mediates HSC Quiescence and Maintains
Reconstitution Function In Vivo
The results presented here establish a role for Wnt, in the main-
tenance of a quiescent fraction of functional HSCs in BM. This
was associated with evidence of increased stem cells on limit di-
lution transplant analysis. However, the ability of the same cells
to function after serial rounds of transplantation was drastically
reduced. The ability of stem cells to persist under the stress con-
ditions of transplantation requires self-renewal capability that is
compromised after Dkk1 exposure.
The studies of inducible deletion of b- and g-catenin noted that
they were dispensable for HSC function; however, they did not
include sequential transplants out to the extent where we ob-
served our most dramatic phenotype (Cobas et al., 2004; Jean-
net et al., 2008; Koch et al., 2008). Alternatively, it is possible that
Dkk1 interferes with HSC function through a process that does
not depend on b- or g-catenin signaling (Jeannet et al., 2008;
Niehrs, 2006).
Our results emphasize the importance of studying pathways
within the context of other signals present in the natural microen-
vironment, and underscore the potential for unanticipated func-
tional roles. It is clear that different combinations of signals may
have a range of effects depending on the context in which they
are received. Indeed, we observed an impact of Wnt inhibition
on the activation of the Notch target, Hes-1, raising the possibil-
ity that Notch andWnt coordinate in vivo to maintain quiescence
of HSCs, rather than participating in expansive and/or self-re-
newal functions (Duncan et al., 2005). Notably, elevated Hes-1
and p21 expression have recently been shown to correlate
with the maintenance of quiescence and repopulating function
of primitive HSCs (Yu et al., 2006). We noted a highly specific im-
pact of the Dkk1 tg on the stem cell-enriched LK+S+ fraction in
Wnt-dependent pathway activation and inhibition and the Notch
target, Hes-1, or the cell-cycle regulator, p21 expression.Cell Stem Cell 2, 274–283, March 2008 ª2008 Elsevier Inc. 279
Cell Stem Cell
Endosteal Wnt Signaling Induces HSC QuiescenceThe effects of Dkk1 on cell cycling were unanticipated given
previous reports of constitutively active b-catenin inducing in-
creased stem/progenitor cell proliferation (Kirstetter et al.,
2006; Scheller et al., 2006). However, others found that with de-
letion of the chromatin binding protein, Hmgb3, Wnt signaling
was increased, yet stem cells more readily returned to quies-
cence after 5-FU challenge than controls (Nemeth et al., 2006).
Both increased and decreased activation of the pathway may
therefore alter HSC cycling kinetics. This may again be due to
the context differences observed with a microenvironmentally
provided signal in the current study contrasted with cell autono-
mous activation of the pathway in the prior reports. Alternatively,
it may be an example of the complex effects of morphogens,
which have dose-dependent actions (Delaney et al., 2005; Kiel-
man et al., 2002; MacDonald et al., 2004). It may be that there
Figure 5. Examination of Cell-Cycle Status of Primi-
tive BM in WT and Dkk1 tg Mice
BMwas isolated from three pairs of WT and Dkk1 tg mice and
subjected to FACS analysis after surface staining and treat-
ment with Hoechst 33342 and Pyronin Y. Proportion of
LK+S+ gated (A) or LK+S+CD34low gated (B) cells present in
gates corresponding to G0, G1, or S-G2-M phases of the
cell cycle (see inset diagram) are depicted for a representative
pair of WT (left) and Dkk1 tg (right) mice. (C) To functionally as-
say the preservation of a quiescent BM fraction, control recip-
ient mice were reconstituted with WT or Dkk1 tg cells and al-
lowed to engraft for 16 weeks. Peripheral neutrophil (NE)
counts were monitored by weekly cbc analysis following intra-
peritoneal injection of 5-FU at day 0 and day 42 (injections in-
dicated by downward arrows). Data indicate mean ± SE for
groups of five recipients per genotype (WT, dashed line;
Dkk1 tg, solid line) and are representative of two independent
experiments (**p < 0.005, *p < 0.05, two-tailed t test).
is a biphasic response of cell cycling to the Wnt
pathway and that proper control of stem cell quies-
cence requires a fine-tuned modulation of interme-
diate Wnt signaling intensity. This has implications
for the potential use of Wnts as mediators of stem
cell expansion ex vivo and for interruption of this
pathway as an antileukemic intervention.
In sum, niche-related expression of Dkk1 reveals
a role for Wnt signaling in the physiologic regulation
of the hematopoietic compartment, altering stem
cell cycling and longevity following repeated ex-
pansion, or self-renewal. The phenotype observed
was sufficiently distinct from what cell-autono-
mous modifications of the pathway would have
predicted to argue for niche-specific modeling of
exogenous factors’ effects on stem cells. This
may be particularly true for members of the locally
acting morphogen group of cell modifiers.
EXPERIMENTAL PROCEDURES
Mice
C57Bl/6 WT, CD45.1 congenic (Jackson), and Col1a-Dkk1 tg
mice were bred in-house in a pathogen-free environment. Un-
less otherwise stated, male Dkk1 tg mice and WT littermates
were studied between 8 and 12 weeks of age. Transplant re-
cipients were female mice at least 12 weeks old. The Subcommittee on Re-
search Animal Care of the Massachusetts General Hospital (MGH) approved
all animal work according to federal and institutional policies and regulations.
Cells and Cell Culture
BM was harvested as previously described (Walkley et al., 2007) and cultured
in CFU-C assays according to the manufacturers’ protocols (Stem Cell Tech-
nologies).
Flow Cytometric Analysis and Sorting of Subpopulations
Lineage staining utilized a cocktail of biotinylated anti-mouse antibodies to
Mac-1 (CD11b), Gr-1 (Ly-6G and 6C), Ter119 (Ly-76), CD33, CD4, CD8a
(Ly-2), and B220 (CD45R) (BD Biosciences). For detection and sorting, we
used streptavidin conjugated with either PE/Cy7, APC/Cy7, or PerCP (BD
Biosciences). Directly conjugated antibodies used were as follows: cKit-
APC (CD117) and Flk2-PE (CD135) (BD Biosciences); Sca1-PE/Cy5.5 (Ly
6A/E, Caltag); and CD34-FITC, CD117-APC/Cy7, CD16/32-Alexa700, and280 Cell Stem Cell 2, 274–283, March 2008 ª2008 Elsevier Inc.
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Endosteal Wnt Signaling Induces HSC QuiescenceIL-7Ra-Pacific Blue (eBioscience). Primitive subpopulations were gated as
shown in Figures S2A–S2C. For congenic strain discrimination, anti-CD45.1-
PE and anti-CD45.2 FITC antibodies (BD Biosciences) were used in combina-
tion with CD11b-APC and B220-Pe/Cy5. For BrdU incorporation, we used the
APC-BrdU Flow Kit (BD Biosciences) according to the manufacturer’s instruc-
tions. BM was assayed 16–18 hr after a single intraperitoneal injection of BrdU
(100 ul of a 10 mg/ml solution) with subsequent access to 1 mg/ml BrdU in
drinking water. Surface staining for lineage markers was performed as above,
with Lin-btn/saPerCP, Sca1-PE/Cy5.5, cKit-APC/Cy7, CD135-PE, and CD34-
FITC. Staining for the primitive BM populations following 5-FU exposure uti-
lized CD150-PE and CD48-FITC conjugates in combination with biotinylated
Lineage cocktail and saAPC.
Transplantation Assays
For serial transplantation, 1 3 106 whole BM cells from 8 to 12 week old WT
and Dkk1 tg (CD45.1) littermates were injected into lethally irradiated (9.5 Gy)
female C57Bl/6 (CD45.2) recipients. Reconstitution was monitored by FACS
analysis of peripheral blood at 4, 8, and 14 weeks posttransplantation. Four-
teen weeks posttransplantation, recipients were used as donors for the sub-
sequent transplantation cycle. Analysis of surviving fractions was calculated
using a Kaplan-Meier plot with Prism graphing software. For limiting dilution/
CRU transplants, doses of 1.5 3 105, 5 3 104, or 1.67 3 104 test cells
(CD45.1) were mixed with 3.0 3 105 competing WT BM cells and trans-
planted intravenously into groups of at least nine lethally irradiated WT recip-
ients, as previously described (Janzen et al., 2006). Reconstitution was as-
sessed at weeks 12 and 24 posttransplantation and analyzed with L-Calc
software (Stem Cell Technologies). For competitive transplants, 5 3 105
BM cells from individual Dkk1 tg or littermate mice (CD45.1) were trans-
planted with the same number of WT BM into each of 8–10 lethally irradiated
WT recipients. Repopulation was assessed by flow cytometry at 8, 16, and
24 weeks by FACS analysis of peripheral blood. For transplantation to as-
sess acute Dkk1 exposure, 1 3 106 WT BM cells were transplanted into
five individual Dkk1 tg or control (CD45.1) lethally irradiated recipients. Re-
constitution was assessed by FACS analysis of peripheral blood at 4, 8,
and 14 weeks. After 14 weeks, groups of five secondary WT CD45.1 recip-
ients received 9 3 105 donor cells (CD45.2) from an individual primary recip-
ient mixed with 3 3 105 fresh CD45.1 BM. Reconstitution was assessed at 4,
12, and 24 weeks.
Hoechst/Py Cell-Cycle Analysis
Unmanipulated WT and Dkk1 tg BM was incubated with 10 ug/ml Hoechst
33342 for 30 min at 37C. Cells were washed and stained with antibodies
against CD34, cKit, Sca1, and Lin. The cells were fixed in 5% PFA, and incu-
bated with an RNA dye, Pyronin Y (PY, 1 mg/ml), prior to flow cytometry. The
proportion of cells in G0 (PYlow, Hoechstlow) was measured in the LK+S+ and
LK+S+CD34low gated populations.
Figure 6. Gene Expression by Quantitative PCR of Sorted
Primitive Populations
BM was isolated from three independent pairs of WT and Dkk1 tg
mice, and LK+S+ (white) or LK+S (gray) populations were sorted
prior to mRNA isolation. Gene expression was assayed by qPCR
for the indicated targets. Data are expressed as the delta-CT be-
tween the gene of interest and the Hprt1 levels expressed in the
same Dkk1 tg sample, relative to the delta-CT observed in the
paired WT sample. Means from three independent experiments
are depicted with SE (Hes-1, p21 p < 0.02).
5-Fluorouracil Assay for Quiescence
To test for retention of a quiescent pool of hematopoietic progen-
itors, groups of five WT recipients were lethally irradiated and
transplanted with 1 million BM cells from individual WT or Dkk1
tg donors (CD45.1) and left to engraft for 16 weeks. A single
150 mg/kg dose of 5-FU (Pharmacia) was administered intraperi-
toneally on days 0 and 42. Peripheral blood cell composition wasmonitored by
tail vein sampling using a Hemavet 850 (Drew Scientific) at day 0, and every
7 days thereafter. Prior to each 5-FU injection, mice were assayed to confirm
complete peripheral blood reconstitution by the original donor CD45.1 popu-
lation (data not shown). For BM analysis, mice were sacrificed 40–42 hr after
5-FU injection. BM cells were isolated and stained for FACS analysis of prim-
itive BM populations.
PCR and Gene Expression Analyses
Gene expressionwas determined as describedpreviously (Janzen et al., 2006).
Briefly, RNA was isolated from sorted BM subpopulations using the PicoPure
Kit (Arcturus Bioscience). Predesigned assays for Hprt1, Bmi-1, Gfi-1, Hes1,
and p21 were purchased from Applied Biosystems (assay IDs Mm00446968,
Mm00776122,Mm00515853, Mm00468601, andMm00432448, respectively).
For analysis of Topgal reporter expression, LK+S+ and LK+S populationswere
sorted from three mice, transgenic either for Topgal alone, or Topgal and Dkk1
tg. Topgal reporter activity was assayed using Applied Biosystems Sybr green
kit with the primers (FW) 50-TAATGTTGATGAAAGCTGGCT-30 and (RV)
50-ATGCGCTCAGGTCAAATTCAG-30. Data are presented as the delta-CT be-
tween the gene of interest and Hprt1 in a given population of Dkk1 tg cells, rel-
ative to the same comparison performed for WT cells. For endogenous and
transgenic Dkk1 expression, in addition to sorted LK+S+ populations, total
RNA was extracted from tibiae (including marrow cells) using Trizol reagents
(Invitrogen, Carlsbad, CA) according to the manufacturer’s protocol. cDNA
was prepared using the SuperScript First-Strand Synthesis system for RT-
PCR (Invitrogen) and analyzed in triplicate with the SYBR Green Master Mix
system (QIAGEN). Primers specific for Dkk1 tg were (FW) 50-AACCTTACTT
CTGTGGTGTGACAT-30 and (RV) 50-AACCTTACTTCTGTGGTGTGACAT-30.
Primers detecting both endogenous and tg Dkk1 were (FW) 50-CTTGCGCT
GAAGATGAGGAGT-30 and (RV) 50-GAGGGCATGCATATTCCATTT-30.
Statistical Analysis
Where not otherwise stated, the Student’s t test was used to determine the
significance, set at p < 0.05.
SUPPLEMENTAL DATA
Supplemental Data include four figures and can be foundwith this article online
at http://www.cellstemcell.com/cgi/content/full/2/3/274/DC1/.
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